Searchable abstracts of presentations at key conferences in endocrinology

ea0032p296 | Clinical case reports - Thyroid / Others | ECE2013

Parathyroid carcinoma

Adamska Agnieszka , Gorska Maria Zofia

Introduction: Parathyroid carcinoma is a rare endocrine malignancy accounting for <1% of all cases of hyperparathyroidism. Diagnosis and treatment is still difficult.Case report: A 32-year-old women was admitted to the hospital because of mental status changes, polyuria, polydipsia, musculoskeletal pain and weight loss (34 kg during last year). She had history of nephrolithiasis, pancreatitis, cholelithiasis, peptic ulcer disease, osteoporosis and di...

ea0037ep816 | Pituitary: clinical | ECE2015

Successful treatment of huge pituitary macroadenoma secreting TSH and GH

Adamska Agnieszka , Zapora-Kurel Agnieszka , Gorska Maria

Introduction: The mixed tumor which secretes an excess of both GH and TSH causing acromegaly and hyperthyroidism is rare. The main problem is the late diagnosis, especially in men, even 10 years after the occurrence of the first symptoms.Case report: A 53-year-old men, was admitted to the our department, with complaints of excessive sweating and enlargement of the hands. His medical history included arterial hypertension. Past medical history revealed th...

ea0049ep31 | Adrenal cortex (to include Cushing's) | ECE2017

The role of CYP11B2 polymorphism in the pathogenesis of hypertension in patients with adrenal incidentaloma

Zukowski Lukasz , Wawrusiewicz-Kurylonek Natalia , Mysliwiec Janusz , Gorska Maria

Background: Significant prevalence of hypertension in the world’s population and its consequences tend to an intensive search for pathogenesis and etiology of this disease. Epidemic of hypertension is accompanied by an epidemic of adrenal incidentaloma and grows in direct proportion to patients age. Polymorphism of aldosterone synthase (CYP11B2) in -344th region of promoter seems to have much in common with hypertension and adrenal incidentaloma.Aim...

ea0041ep37 | Adrenal cortex (to include Cushing's) | ECE2016

CYP11B2 polymorphism affects the aldosterone – renin ratio?

Zukowski Lukasz , Mysliwiec Janusz , Wawrusiewicz-Kurylonek Natalia , Gorska Maria

Introduction: Nowadays is believed that primary aldosteronism (PA) is the most frequent cause of secondary hypertension and reaches 10% of whole hypertensive population. The activity of the mineralocorticoid hormone may be change by polymorphism of aldosterone synthase gene (CYP11B2) e.g. in promoter -344T/C region. Aim of this study was to find differences in baseline plasma aldosterone concentration (PAC), plasma renin activity (PRA), aldosterone – renin ratio (ARR) and...

ea0041ep265 | Clinical case reports - Pituitary/Adrenal | ECE2016

Late complications in a man with poorly controlled congenital adrenal hyperplasia – case report

Maliszewska Katarzyna , Kowalska Irina , Poplawska-Kita Anna , Gorska Maria

Introduction: We report a case of CAH who developed several complications due to poor control. Proper diagnosis and treatment can enable men with the disease to have a normal life and fertility. Case report 39-year-old patient with a history of primary adrenal insufficiency was admitted to our department because of infertility. Semen analysis performed prior to hospitalization showed azoospermia. The patient did not have medical documentation regarding his disease and was not ...

ea0020p62 | Thyroid | ECE2009

Soluble CD40 and its ligand CD154 in patients with Graves’ orbitopathy during combined therapy with corticosteroids and teleradiotherapy

Mysliwiec Janusz , Waligorski Dariusz , Nikolajuk Agnieszka , Gorska Maria

It was shown recently that orbital fibroblasts express intensively CD40 and its ligation stimulates proinflammatory cytokines, glicosoaminoglycans and PGE2 production. CD40/CD154 interaction in the pathogenesis of Graves’ orbitopathy (GO) is suggested an important pathway of T cells induced fibroblast activation and proliferation.Aim: To assess the role of CD40/CD154 interaction in GO pathogenesis and to estimate usefulness of soluble CD4...

ea0020p278 | Clinical case reports and clinical reports | ECE2009

Cushing syndrome caused by topical corticosteroids coexistent with pituitary incidentaloma – case report

Karczewska-Kupczewska Monika , Adamska Agnieszka , Kowalska Irina , Gorska Maria

Iatrogenic Cushing syndrome caused by the use of steroid medications is common because of the widespread use of these medications for the treatment of many diseases, however development of Cushing syndrome from the topical corticosteroids is very rare in adults.A 45-year-old men (BMI: 44 kg/m2), with a history of psoriasis, developed manifestations of Cushing syndrome, which included weight gain, central obesity, moon face, facial plethora, bu...

ea0016p744 | Thyroid | ECE2008

Assessment of VEGF, VEGF receptor, EGF and endostatin concentrations in patients with endemic goiter

Zarzycki Wieslaw , Zonenberg Anna , Modzelewska Anna , Nikolajuk Agnieszka , Gorska Maria

Tumor angiogenesis is believed to result from an imbalance of pro- and anti-angiogenic factors. Angiogenesis is an important component in the development of thyroid goitre. Vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF) represents a family of specific endothelial cell mitogens involved in normal angiogenesis and in tumor development. Consequently, a panel of anti-angiogenic factors was addressed in a representative sample of VEGF receptor-2 (VEGFR-...

ea0014oc5.7 | Thyroid basic | ECE2007

The 1188A/C polymorphism of IL-12 gene in Graves’ disease

Wawrusiewicz-Kurylonek Natalia , Gorska Maria , Mysliwiec Janusz , Kretowski Adam Jacek

Background and aims: Interleukin-12 (IL-12) is a pro inflammatory cytokine, which was suggested to play a key role in the pathogenesis of Th1-cell-mediated autoimmune diseases. The aim of our study was to estimate the association of 1188A/C polymorphism of IL12B gene with the predisposition to Graves’ disease (GD) in Polish population.Materials and methods: The study was performed in the group consisting of 245 individuals with GD sequentially recru...

ea0014p327 | (1) | ECE2007

Selected markers of endothelial dysfunction in patients with subclinical and overt hyperthyroidism

Modzelewska Anna , Szelachowska Malgorzata , Zonenberg Anna , Gorska Maria

Objective: The aim of this study was to evaluate the influence of subclinical and overt hyperthyroidism on the chosen markers of endothelial function.Material and methods: The groups studied consisted of 97 hyperthyroid subjects (51 with subclinical and 46 with overt hyperthyroidism) and 39 healthy controls matched for age, gender and body mass index. The following parameters were measured: TSH, FT3, FT4 (by MEIA), VCAM-1 (vascular cell adhesion molecule...